(Total Views: 715)
Posted On: 04/09/2022 9:48:43 AM
Post# of 154891
I wonder WHO the colleague was that referred Dr. Yang to Leronlimab...prior to Ms. Moffat's treatment of the same.
Seen as how WE now seem to be so centered on FACTS... and the science of it all.
Based on facts (only)...what do the results of the 350 mg administered to enrollees... (NASH) tell us about the likely extrapolated results from the larger dose (700 mg)?...anyone who knows...fact-based results on comparative/similar studies. We can whine about 4 doses vs 2 doses...but, let's keep it real.
Seen as how WE now seem to be so centered on FACTS... and the science of it all.
Based on facts (only)...what do the results of the 350 mg administered to enrollees... (NASH) tell us about the likely extrapolated results from the larger dose (700 mg)?...anyone who knows...fact-based results on comparative/similar studies. We can whine about 4 doses vs 2 doses...but, let's keep it real.
(0)
(0)
